Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00366821 · ClinicalTrials.gov registry record
Retrospective Review of the Outcomes of Newborns With Genetic Abnormalities
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT00366821: Completed study, sponsored by Children's Healthcare of Atlanta.
NCT00366821 is a clinical trial that has completed, run by Children's Healthcare of Atlanta. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00366821 has completed, sponsored by Children's Healthcare of Atlanta.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
Our hope is that the information from this retrospective study will provide information to better serve our patients and their parents with risk stratification (levels of risk) and clinical expectations of patients after cardiac surgery who have genetic abnormalities and those who do not have genetic abnormalities.
Primary Outcome
We wish to examine the outcomes following cardiac surgery in newborns with genetic abnormalities compared to those newborns without genetic abnormalities.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2002-01 |
| Est. Completion | 2014-11 |
What the finished NCT00366821 record still lists
NCT00366821 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00366821 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00366821 about?
NCT00366821 is a clinical study titled "Retrospective Review of the Outcomes of Newborns With Genetic Abnormalities". Our hope is that the information from this retrospective study will provide information to better serve our patients and their parents with risk stratification (levels of risk) and clinical expectations of patients after cardiac surgery who have genetic abnormalities and those who do not have geneti...
What is the current status of trial NCT00366821?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2002-01. Estimated completion is 2014-11.
Who is sponsoring clinical trial NCT00366821?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia